Xellia Pharmaceuticals 401(K) Plan — Form 5500 plan (Xellia Pharmaceuticals Usa LLC)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Xellia Pharmaceuticals 401(K) Plan is a benefit plan reported by Xellia Pharmaceuticals Usa LLC under EIN 47-1150410 and plan number 001. The latest loaded filing year is 2023. The filing reports 457 participants and $22,532,767 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Xellia Pharmaceuticals Usa LLC
EIN
47-1150410
Plan number
001
Plan type
2
Location
Buffalo Grove, IL
Latest filing year
2023
Participants
457
End-of-year plan assets
$22,532,767

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023457H, C20240923065327NAL0006480963001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$22,532,767
Total liabilities (EOY)
$0
Net assets (EOY)
$22,532,767
Net assets (BOY)
$17,360,592

Income & contributions

Employer contributions
$1,102,629
Participant contributions
$2,613,946
Total contributions
$4,340,767
Total income / additions
$7,806,185

Expenses & distributions

Benefits paid
$2,509,506
Administrative expenses
$80,380
Total expenses
$2,634,010
Net increase / (decrease)
$5,172,175

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Fidelity Workplace Services LLCPLAN ADMINISTRATOR$55,380$02023
Gallagher Fiduciary Advisors LLCADVISOR$25,000not reported in the loaded dataset2023

Related Form 5500 pages